Nicola Normanno

5 ta ish

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

1. Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group

   Fernanda Mosele, Jordi Remón, Joaquı́n Mateo +19

   Sharh maqolaOAOchiq kirish20202 iqtibos

   ABIABI:AkademIndex/2026.other.079148

2. ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group

   Javier Pascual, Gerhardt Attard, François‐Clément Bidard +17

   MaqolaOAOchiq kirish20222 iqtibos

   ABIABI:AkademIndex/2026.other.079157

3. Interpreting and integrating genomic tests results in clinical cancer care: Overview and practical guidance

   Raffaella Casolino, Philip Beer, Debyani Chakravarty +9

   Sharh maqolaOAOchiq kirish20242 iqtibos

   ABIABI:AkademIndex/2026.other.079168

4. Epidermal growth factor receptor (EGFR) signaling in cancer

   Nicola Normanno, Antonella De Luca, Caterina Bianco +7

   Sharh maqola20052 iqtibos

   ABIABI:AkademIndex/2026.other.219445

5. Empowering effective biomarker-driven precision oncology: A call to action

   Mark Lawler, Peter Keeling, Olga Kholmanskikh +13

   Sharh maqolaOAOchiq kirishCancer Genomics and DiagnosticsEuropean Journal of Cancer20240 iqtibos

   ABIABI:AkademIndex/2024.review-article.000008